Preview

Journal Biomed

Advanced search

Metabolic, Blood Cell and Bone Marrow Status in db/db Mice Treated with Lactoferrin at Various Stages of Type 2 Diabetes Mellitus

https://doi.org/10.33647/2074-5982-21-3-47-52

Abstract

The use of Lactoferrin (Lf) for treating stages I and II of type 2 diabetes mellitus (DM2) initially stabilized the glucose level and weight of db/db mice, followed by normalization of these parameters after the drug discontinuation. By the end of Lf usage at stage III of DM2, these parameters in the animals sharply decreased, leading to their rapid death. In all experiments, under Lf treatment at stages I, II, and III of DM2, the oxidative metabolism index (OMI) was initially decreasing, followed by its growth to higher than the initial level at stages I and II of DM2 after the drug discontinuation, and was sharply decreasing again at stage III. The corresponding stress-adaptive changes were also revealed for blood cells and bone marrow, the development of which was carried out with the participation of programmed cell death mechanisms. Lf used to correct clinical manifestations of DM2 acts as a powerful adaptogen. It is capable of exerting an adjuvant effect on the metabolism and state of blood and bone marrow cells, but only at early stages with preserved adaptive reserves in the body.

About the Authors

O. I. Stepanova
Scientific Center of Biomedical Technologies of the Federal Medical and Biological Agency of Russia
Russian Federation

Olga I. Stepanova - Cand. Sci. (Biol.).

143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1



R. A. Klesov
Scientific Center of Biomedical Technologies of the Federal Medical and Biological Agency of Russia
Russian Federation

Roman A. Klesov

143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1



Kh. Kh. Semenov
Scientific Center of Biomedical Technologies of the Federal Medical and Biological Agency of Russia
Russian Federation

Khyzyr Kh. Semenov - Cand. Sci. (Biol.).

143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1



N. A. Onishchenko
Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Health Care of Russia
Russian Federation

Nina A. Onishchenko - Dr. Sci. (Med.), Prof.

123182, Moscow, Shchukinskaya Str., 1



A. O. Nikolskaya
Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Health Care of Russia
Russian Federation

Alla O. Nikolskaya - Cand. Sci. (Biol.)

123182, Moscow, Shchukinskaya Str., 1



G. A. Puzyreva
Research Institute of General Pathology and Pathophysiology
Russian Federation

Galina A. Puzyreva

125315, Moscow, Baltiyskaya Str., 8



I. B. Alchinova
Research Institute of General Pathology and Pathophysiology
Russian Federation

Irina B. Alchinova - Cand. Sci. (Biol.)

125315, Moscow, Baltiyskaya Str., 8



M. S. Demorzhi
Research Institute of General Pathology and Pathophysiology
Russian Federation

Marina S. Demorzhi

125315, Moscow, Baltiyskaya Str., 8



A. B. Cherepov
Research Institute of General Pathology and Pathophysiology
Russian Federation

Anton B. Cherepov

125315, Moscow, Baltiyskaya Str., 8



A. A. Metelkin
Research Institute of General Pathology and Pathophysiology
Russian Federation

Arkady A. Metelkin

125315, Moscow, Baltiyskaya Str., 8



M. V. Nesterenko
Lactobio LLC
Russian Federation

Mikhail V. Nesterenko - Dr. Sci. (Biol.).

119331, Moscow, Vernadsky Ave., 29



Yu. B. Basok
Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Health Care of Russia
Russian Federation

Yulia B. Basok - Dr. Sci. (Med.).

123182, Moscow, Shchukinskaya Str., 1



References

1. Stepanova O.I., Klesov R.A., Semenov Kh. Kh., Pomytkin I.A., Onishchenko N.A., Karkischenko V.N. Sposob neinvazivnogo izucheniya tkanevyh narushenij pri saharnom diabete 2 tipa u myshej db/db c pomoshch'yu lazernoj dopplerovskoj fluometrii [A method for noninvasive studying tissue disorders in type 2 diabetes mellitus in db/db mice using laser Dopple Experimental Therapy]. 2023;67(2):118–129. (In Russian). DOI: 10.25557/00312991.2023.02.118-129.


Review

For citations:


Stepanova O.I., Klesov R.A., Semenov Kh.Kh., Onishchenko N.A., Nikolskaya A.O., Puzyreva G.A., Alchinova I.B., Demorzhi M.S., Cherepov A.B., Metelkin A.A., Nesterenko M.V., Basok Yu.B. Metabolic, Blood Cell and Bone Marrow Status in db/db Mice Treated with Lactoferrin at Various Stages of Type 2 Diabetes Mellitus. Journal Biomed. 2025;21(3):47-52. (In Russ.) https://doi.org/10.33647/2074-5982-21-3-47-52

Views: 6


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-5982 (Print)
ISSN 2713-0428 (Online)